Lin Mei, MD
Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
View 1 additional location
Make an appointmentCall 215-615-5858
Headshot of Lin Mei, MD
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Medicine (Hematology-Oncology)

Education and training

  • Medical School: Beijing Medical University
  • Residency: Buffalo General Medical Center
  • Fellowship: University of Virginia Health System

What my patients think about me

Average Rating

321 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
February 2026
he's just not david vaughn
Anonymous
February 2026
professional, thorough.
Anonymous
February 2026
the doctor was straight forward, helpful and just did an outstanding overall consultation.
Anonymous
February 2026
very knowledgeable and willing to explain everything. very willing to answer questions.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Mei is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Subramanian P, Barsouk A, Elghawy O, Sussman JH, Yaskolko M, Yang A, Xu J, and Mei L. EGFR, HER2 alterations in advanced urothelial carcinoma (aUC): A retrospective analysis on survival outcomes. , American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fran, CA., 44(7): 2026,787

Nair RP, Du W, Mei L, Koga S. Artificial intelligence for detection, grading, and prognostication in prostate cancer pathology: A scoping review , Histol Histopathol: 2026

Litt HK, Wodzinski A, Subramanian P, Donovan M, Vapiwala N, Parikh RB, Narayan V, Mei L, Takvorian SU, Balzer Haas N, Mistry R, and Mamtani R. OncoEducate: A pilot study of generative AI to support patient education in GU cancer care. , American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fran, CA., 44(7): 2026,713

Barsouk AA, Yang A, Sussman JH, Elghawy O, Xu J, Xu J, Meng L, Koga S, Du W, Mamtani R, Mei L. Survival Disparities by Sex, Race, and Age in the Era of Contemporary Advanced Urothelial Carcinoma Therapy: A Real-World Analysis , Clin Genitourin Cancer, 23(5): 2025,102395

Koga S, Mei L. Perioperative Durvalumab in Bladder Cancer , American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco, CA.: 2025

Koga S, Mei L. Perioperative Durvalumab in Bladder Cancer , N Engl J Med, 392(6): 2025,618-619

Adam Barsouk, Omar Elghawy, Austin Yang, Jonathan H. Sussman, Ronac Mamtani and Lin Mei Meta-Analysis of Age, Sex, and Race Disparities in the Era of Contemporary Urothelial Carcinoma Treatment , Cancers, 16(19): 2024,3338

Wei Du, Lin Mei A case report of pegcetacoplan use for a pregnant woman with paroxysmal nocturnal hemoglobinuria , Res Pract Thromb Haemost, 8(4): 2024,102435

Du W, Estalilla OC, Jelic TM, Hayes JD, Tobin EC, Mei L. Bone marrow involvement by breast implant-associated anaplastic large cell lymphoma. , Br J Haematol , 198(6): 2022,938

Du W, Sirbu C, Lucas BD Jr, Jubelirer SJ, Khalid A, Mei L A Retrospective Study of Brain Metastases from Solid Malignancies: The Effect of Immune Checkpoint Inhibitors. , Front Oncol , 27: 2021,11:667847